Pelthos Therapeutics(PTHS)
$6.38-0.61 (-8.73%)
PTHS
Pelthos Therapeutics hedge funds
$6.38
At close:-0.61 (-8.73%)
Want to see PTHS full AI Analyst Report?
Pelthos Therapeutics (PTHS) Hedge Fund Trading Activity
77 Followers
Trend: ▲ Hedge Funds Increased Holdings by 62.0K Shares Last Quarter
Hedge Fund Holdings in PTHS
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Wexford Capital LP | Added | 278.36% | $1,777,782 | 0.23% | |||
| Reduced | -4.34% | $107,004 | <0.01% |
FAQ
Which hedge funds hold Pelthos Therapeutics?
Currently, no data Available
Are hedge funds buying or selling PTHS?
In the last quarter hedge funds have Increased their holdings in Pelthos Therapeutics by 62.0K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Pelthos Therapeutics stock?
Warren Buffet currently does not own shares in Pelthos Therapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here

